A Novel , , and Standard That Improves Accuracy in Quantifying Bacterial Burden in Vaginal Microbial Communities
Overview
Infectious Diseases
Microbiology
Authors
Affiliations
Bacterial vaginosis (BV) is the most common vaginal dysbiosis. In this condition, a polymicrobial biofilm develops on vaginal epithelial cells. Accurately quantifying the bacterial burden of the BV biofilm is necessary to further our understanding of BV pathogenesis. Historically, the standard for calculating total bacterial burden of the BV biofilm has been based on quantifying 16S rRNA gene copy number. However, is improper for measuring the bacterial burden of this unique micro-environment. Here, we propose a novel qPCR standard to quantify bacterial burden in vaginal microbial communities, from an optimal state to a mature BV biofilm. These standards consist of different combinations of vaginal bacteria including three common BV-associated bacteria (BVAB) spp. (G), spp. (P), and spp. (F) and commensal spp. (L) using the 16S rRNA gene (G:P:F:L, G:P:F, G:P:L and 1G:9L). We compared these standards to the traditional (E) reference standard using known quantities of mock vaginal communities and 16 vaginal samples from women. The E standard significantly underestimated the copy numbers of the mock communities, and this underestimation was significantly greater at lower copy numbers of these communities. The G:P:L standard was the most accurate across all mock communities and when compared to other mixed vaginal standards. Mixed vaginal standards were further validated with vaginal samples. This new G:P:L standard can be used in BV pathogenesis research to enhance reproducibility and reliability in quantitative measurements of BVAB, spanning from the optimal to non-optimal (including BV) vaginal microbiota.
Microbiota and Recurrent Pregnancy Loss (RPL); More than a Simple Connection.
Garmendia J, De Sanctis C, Hajduch M, De Sanctis J Microorganisms. 2024; 12(8).
PMID: 39203483 PMC: 11357228. DOI: 10.3390/microorganisms12081641.
Oyenihi A, Haines R, Trama J, Faro S, Mordechai E, Adelson M Front Cell Infect Microbiol. 2024; 14:1409774.
PMID: 39006741 PMC: 11239351. DOI: 10.3389/fcimb.2024.1409774.
Lameira I, Pinto A, Lima A, Muzny C, Cerca N J Microbiol Methods. 2024; 219:106895.
PMID: 38331102 PMC: 11149788. DOI: 10.1016/j.mimet.2024.106895.
Muzny C, Elnaggar J, Sousa L, Lima A, Aaron K, Eastlund I BMJ Open. 2024; 14(2):e083516.
PMID: 38316599 PMC: 10859992. DOI: 10.1136/bmjopen-2023-083516.
Association of burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment.
Ardizzone C, Taylor C, Toh E, Lillis R, Elnaggar J, Lammons J Front Cell Infect Microbiol. 2023; 13:1289449.
PMID: 38149008 PMC: 10750252. DOI: 10.3389/fcimb.2023.1289449.